Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Herbimycin A induces the 20 S proteasome- and ubiquitin-dependent degradation of receptor tyrosine kinases.

Sepp-Lorenzino L, Ma Z, Lebwohl DE, Vinitsky A, Rosen N.

J Biol Chem. 1995 Jul 14;270(28):16580-7.

PMID:
7622464
[PubMed - indexed for MEDLINE]
Free Article
2.

Effect of herbimycin A on tyrosine kinase receptors and platelet derived growth factor (PDGF)-induced signal transduction.

Murakami Y, Fukazawa H, Mizuno S, Uehara Y.

Biol Pharm Bull. 1998 Oct;21(10):1030-5.

PMID:
9821805
[PubMed - indexed for MEDLINE]
3.

Effects of geldanamycin, a heat-shock protein 90-binding agent, on T cell function and T cell nonreceptor protein tyrosine kinases.

Yorgin PD, Hartson SD, Fellah AM, Scroggins BT, Huang W, Katsanis E, Couchman JM, Matts RL, Whitesell L.

J Immunol. 2000 Mar 15;164(6):2915-23.

PMID:
10706677
[PubMed - indexed for MEDLINE]
Free Article
4.

Identification of an ubiquitin-ligation system for the epidermal-growth-factor receptor--herbimycin A induces in vitro ubiquitination in rabbit-reticulocyte lysate.

Mori S, Tanaka K, Kanaki H, Nakao M, Anan T, Yokote K, Tamura K, Saito Y.

Eur J Biochem. 1997 Aug 1;247(3):1190-6.

PMID:
9288947
[PubMed - indexed for MEDLINE]
Free Article
5.

Involvement of the ubiquitin-proteasome pathway in the degradation of nontyrosine kinase-type cytokine receptors of IL-9, IL-2, and erythropoietin.

Yen CH, Yang YC, Ruscetti SK, Kirken RA, Dai RM, Li CC.

J Immunol. 2000 Dec 1;165(11):6372-80.

PMID:
11086075
[PubMed - indexed for MEDLINE]
Free Article
6.

Specific inhibition of cytoplasmic protein tyrosine kinases by herbimycin A in vitro.

Fukazawa H, Li PM, Yamamoto C, Murakami Y, Mizuno S, Uehara Y.

Biochem Pharmacol. 1991 Oct 9;42(9):1661-71.

PMID:
1656993
[PubMed - indexed for MEDLINE]
7.

Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway.

Jeffers M, Taylor GA, Weidner KM, Omura S, Vande Woude GF.

Mol Cell Biol. 1997 Feb;17(2):799-808.

PMID:
9001234
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

[Ligand-induced polyubiquitination of receptor tyrosine kinases].

Mori S.

Tanpakushitsu Kakusan Koso. 1997 Oct;42(14 Suppl):2284-90. Review. Japanese. No abstract available.

PMID:
9366209
[PubMed - indexed for MEDLINE]
10.

Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.

Bonvini P, An WG, Rosolen A, Nguyen P, Trepel J, Garcia de Herreros A, Dunach M, Neckers LM.

Cancer Res. 2001 Feb 15;61(4):1671-7.

PMID:
11245482
[PubMed - indexed for MEDLINE]
Free Article
11.
12.

Heregulin beta1 induces the down regulation and the ubiquitin-proteasome degradation pathway of p185HER2 oncoprotein.

Magnifico A, Tagliabue E, Ardini E, Casalini P, Colnaghi MI, Ménard S.

FEBS Lett. 1998 Jan 30;422(2):129-31.

PMID:
9489990
[PubMed - indexed for MEDLINE]
Free Article
13.

Labeling of v-Src and BCR-ABL tyrosine kinases with [14C]herbimycin A and its use in the elucidation of the kinase inactivation mechanism.

Fukazawa H, Uehara Y, Murakami Y, Mizuno S, Hamada M, Takeuchi T.

FEBS Lett. 1994 Mar 7;340(3):155-8.

PMID:
8131836
[PubMed - indexed for MEDLINE]
Free Article
14.

Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signaling pathway.

Clark JW, Santos-Moore A, Stevenson LE, Frackelton AR Jr.

Int J Cancer. 1996 Jan 17;65(2):186-91.

PMID:
8567115
[PubMed - indexed for MEDLINE]
15.

Does the mechanism responsible for TNF-mediated insulin resistance involve the proteasome?

Pallarés-Trujillo J, Carbó N, López-Soriano FJ, Argilés JM.

Med Hypotheses. 2000 Apr;54(4):565-9.

PMID:
10859639
[PubMed - indexed for MEDLINE]
16.

The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70.

Fisher EA, Zhou M, Mitchell DM, Wu X, Omura S, Wang H, Goldberg AL, Ginsberg HN.

J Biol Chem. 1997 Aug 15;272(33):20427-34.

PMID:
9252351
[PubMed - indexed for MEDLINE]
Free Article
17.
18.

Tyrosine kinase-dependent modulation of 3-hydroxy-3-methylglutaryl-CoA reductase in human breast adenocarcinoma SKBR-3 cells.

Asslan R, Pradines A, Favre G, Le Gaillard F.

Biochem J. 1998 Feb 15;330 ( Pt 1):241-6.

PMID:
9461516
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Geldanamycin-induced destabilization of Raf-1 involves the proteasome.

Schulte TW, An WG, Neckers LM.

Biochem Biophys Res Commun. 1997 Oct 29;239(3):655-9.

PMID:
9367823
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk